| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 175mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 15mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg/mL + iodine 200mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Radioiodine uptake study |
Using substance (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine poisoning |
Causative agent (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 175mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Free iodine (substance) |
Is a |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Inorganic iodine |
Is a |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing iodine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine- and potassium iodide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing iodine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Fetal iodine syndrome refers to symptoms and signs that may be observed in a fetus or newborn when the mother was exposed during pregnancy to inappropriate (insufficient or excessive) amounts of iodine. Iodine deficiency is associated with goitre and hypothyroidism. When severe iodine deficiency occurs during pregnancy, it is associated with congenital hypothyroidism that is manifested by increased neonatal morbi-mortality and severe mental dysfunction, hyperactivity, attention disorders and a substantial decrease of IQ of an irreversible nature. Excessive iodine ingestion during the third trimester of pregnancy can result in hypothyroidism and fetal goitre due to a prolonged inhibition of thyroid hormone synthesis, an increase in thyrotropin (TSH). |
Causative agent (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing ethanol and iodine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Iodine modified diet |
Direct substance |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Increased iodine diet (regime/therapy) |
Direct substance |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Decreased iodine diet |
Direct substance |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine supplement therapy (regime/therapy) |
Direct substance |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Protein-bound iodine |
Is modification of (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing iodine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine compounds adverse reaction (disorder) |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing iodine and isopropyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Iodine 0.7%/isopropyl alcohol 74% w/w topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely iodine (as iotrolan) 2.4 gram/10 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iododerma |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Exposure to iodine |
Causative agent (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only ethanol and iodine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only iodine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine and isopropyl alcohol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only iodine and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Iodine and potassium iodide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only iodine and potassium iodide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iotrolan) 240 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergic contact dermatitis caused by iodine (disorder) |
Causative agent (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as povidone iodine) 100 mg/g vaginal gel |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Estimated quantity of intake of iodine in 24 hours (observable entity) |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
6 |
| Contact dermatitis caused by iodine (disorder) |
Causative agent (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine intake (observable entity) |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Measured quantity of intake of iodine in 24 hours |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
| Estimated required quantity of intake of iodine in 24 hours |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
| Administration of prophylactic iodine for iodine deficiency goitre |
Direct substance |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as iopromide) 370 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iopromide) 300 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iopromide) 240 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as iopamidol) 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as iopamidol) 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iopamidol) 370 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iomeprol) 350 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iomeprol) 400 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as iomeprol) 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iomeprol) 250 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iohexol) 350 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as iohexol) 240 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as iohexol) 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iodixanol) 270 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as iodixanol) 320 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as iopamidol) 340 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine 50 mg/mL and potassium iodide 100 mg/mL cutaneous solution |
Has precise active ingredient |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine 50 mg/mL and potassium iodide 100 mg/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing iodine and potassium iodide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only iodine and potassium iodide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Estimated quantity of intake of iodine in 24 hours (observable entity) |
Process acts on |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Iodine intake (observable entity) |
Process acts on |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Measured quantity of intake of iodine in 24 hours |
Process acts on |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
| Iodine 25 mg/mL and potassium iodide 25 mg/mL cutaneous solution |
Has precise active ingredient |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine 25 mg/mL and potassium iodide 25 mg/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as iotroxate meglumine) 50 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely iodine (as ethiodized oil) 190 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine (as ethiodised oil) 480 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Estimated required quantity of intake of iodine in 24 hours |
Process acts on |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
| Estimated quantity of intake of iodine in 24 hours (observable entity) |
Process acts on |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Estimated required quantity of intake of iodine in 24 hours |
Process acts on |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine intake (observable entity) |
Process acts on |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Measured quantity of intake of iodine in 24 hours |
Process acts on |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]